Henlius Biotech (02696.HK) said it has entered a strategic collaboration with Sandoz to develop up to 10 monoclonal antibody and/or antibody‑drug conjugate (ADC) biosimilars or components. The parties signed terms covering an initial three selected products and an option on a fourth. In April 2025 the firms agreed exclusive commercialization for Henlius’ ipilimumab biosimilar HLX13 across 46 countries including the US and Europe; the new arrangement deepens their existing oncology biosimilar coo

Iran's agriculture minister said most agricultural operations have been integrated into smart systems and are under comprehensive control, and that assertions of complete food security rest on the ministry's full command of those information systems.

BHP will publish full-year results before the ASX opens on Tuesday. Analysts compiled by Visible Alpha forecast 12-month underlying profit to June of $12.66bn, versus $10.16bn a year earlier. Higher copper, iron ore and coking-coal prices are expected to boost earnings; copper remains the primary market focus as BHP seeks greater exposure to the metal. BHP said copper was the largest contributor to group earnings in 1H FY2026 and plans investor site visits to its South Australia copper operations later this year, which it identifies as a growth priority.